Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12

Molecular and Cellular Biology

Volumn 20, Issue 23, 2000, Pages 8783-8792

  Lee, K S ^a   Kim, H J ^a   Li, Q L ^a   Chi, X Z ^a   Ueta, C ^a   Komori, T ^a   Wozney, J M ^a   Kim, E G ^a   Choi, J Y ^a   Ryoo, H M ^a   Bae, S C ^a  

^a Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN 2; GENE PRODUCT; SMAD PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; MESENCHYME CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MESODERM; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOGENESIS; PHOSPHOPROTEINS; PROTEIN BINDING; RESPONSE ELEMENTS; SMAD5 PROTEIN; STEM CELLS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA;

EID: 0034460993     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.23.8783-8792.2000     Document Type: Article

References (57)

1. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts
2. Isolation of PEBP2 αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1
3. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials
4. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF
5. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone specific complex
6. Role of transforming growth factor-beta in bone remodeling
7. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2
8. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain
9. Expression of a single transfected cDNA converts fibroblasts to myoblasts
10. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
11. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation
12. Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line
13. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter
14. Cbfa1 isoforms exert functional differences in osteoblast differentiation
15. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
16. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
17. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
18. MADR1, a MAD-related protein that functions in BMP2 signaling pathways
19. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer
20. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
21. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
22. The fibronectin gene as a model for splicing and transcription studies
23. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2
24. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia
25. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta 1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
26. Smad2 overexpression enhances Smad4 gene expression and suppresses CBFA1 gene expression in osteoblastic osteosarcoma ROS17/2.8 cells and primary rat calvaria cells
27. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression
28. Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation
29. Regulation of transcription of the germline Ig alpha constant region gene by an ATF element and by novel transforming growth factor-beta 1-responsive elements
30. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
31. The transforming growth factor-beta family
32. TGF-beta signal transduction
33. Sequence specificity of the core-binding factor
34. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
35. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts
36. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12
37. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells
38. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene
39. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha
40. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
41. Bone and cartilage differentiation
42. Transforming growth factor beta: Biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis
43. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
44. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta
45. CBF alpha3 (AML2) is induced by TGF-betal to bind and activate the mouse germline Ig alpha promoter
46. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): Evidence for a new myc collaborating oncogene
47. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ
48. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
49. Expression of the PEBP2alphaA/ AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells
50. Purification and characterization of other distinct bone-inducing factors
51. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
52. Novel regulators of bone formation: Molecular clones and activities
53. Regulation of Smad activity
54. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts
55. Regulation of Smad signalling by protein associations and signalling crosstalk